Inhibition of contact-mediated activation of factor XI protects baboons against S aureus-induced organ damage and death.

Blood Advances
Robert SilasiFlorea Lupu

Abstract

Staphylococcus aureus infections can produce systemic bacteremia and inflammation in humans, which may progress to severe sepsis or septic shock, even with appropriate antibiotic treatment. Sepsis may be associated with disseminated intravascular coagulation and consumptive coagulopathy. In some types of mouse infection models, the plasma coagulation protein factor XI (FXI) contributes to the pathogenesis of sepsis. We hypothesize that FXI also contributes to the pathogenesis of sepsis in primates, and that pharmacological interference with FXI will alter the outcome of Staphylococcus aureus-induced lethality in a baboon model. Pretreatment of baboons with the anti-FXI antibody 3G3, a humanized variant of the murine monoclonal 14E11 that blocks FXI activation by FXIIa, substantially reduced the activation of coagulation, as reflected by clotting times and plasma complexes of coagulation proteases (FXIIa, FXIa, FIXa, FXa, FVIIa, and thrombin) with serpins (antithrombin or C1 inhibitor) following infusion of heat-inactivated S aureus 3G3 treatment reduced fibrinogen and platelet consumption, fibrin deposition in tissues, neutrophil activation and accumulation in tissues, cytokine production, kininogen cleavage, cell death, and co...Continue Reading

References

Apr 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·J H Griffin
Sep 2, 1991·Science·D Gailani, G J Broze
Jul 18, 1991·The New England Journal of Medicine·R AsakaiU Seligsohn
Mar 10, 2001·The New England Journal of Medicine·G R BernardUNKNOWN Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group
Mar 1, 2005·Journal of Thrombosis and Haemostasis : JTH·X WangD Gailani
May 22, 2008·The Journal of Infectious Diseases·Erik I TuckerAndrás Gruber
Jun 24, 2011·Science Translational Medicine·Neil M GoldenbergWarren L Lee
Aug 3, 2011·Journal of Leukocyte Biology·Asako ItakuraOwen J T McCarty
Aug 20, 2011·Chest·Gagan KumarUNKNOWN Milwaukee Initiative in Critical Care Outcomes Research (MICCOR) Group of Investigators
Oct 7, 2011·Journal of Cellular and Molecular Medicine·Fletcher B TaylorFlorea Lupu
Oct 7, 2011·Blood·Sharon H ChoiJames H Morrissey
May 24, 2012·The New England Journal of Medicine·V Marco RanieriUNKNOWN PROWESS-SHOCK Study Group
Feb 13, 2013·Proceedings of the National Academy of Sciences of the United States of America·Junhee SeokUNKNOWN Inflammation and Host Response to Injury, Large Scale Collaborative Research Program
Mar 15, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Deyan LuoStephen T Smiley
Aug 30, 2013·The New England Journal of Medicine·Derek C Angus, Tom van der Poll
Feb 21, 2014·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·C SuffrittiM Cicardi
Dec 11, 2014·Critical Care Medicine·Ryan ZarychanskiUNKNOWN Canadian Critical Care Trials Group
Jan 13, 2015·American Journal of Physiology. Lung Cellular and Molecular Physiology·Angelo Y MelitonKonstantin G Birukov
Jan 16, 2015·Current Opinion in Anaesthesiology·Jeff Simmons, Jean-Francois Pittet
May 16, 2015·Journal of Thrombosis and Haemostasis : JTH·D GailaniA Gruber
Mar 25, 2016·Journal of Intensive Care·Kohji OkamotoYusuke Sawatsubashi
May 1, 2016·The Journal of Allergy and Clinical Immunology·Steven de MaatCoen Maas
May 14, 2016·Arteriosclerosis, Thrombosis, and Vascular Biology·David Gailani, Andras Gruber
May 25, 2016·Expert Review of Hematology·Allison P Wheeler, David Gailani
Oct 27, 2016·Immunological Reviews·Berhane GhebrehiwetEllinor I B Peerschke
Dec 4, 2016·American Journal of Physiology. Lung Cellular and Molecular Physiology·Ingrid StrooTom van der Poll
Apr 15, 2017·The Journal of Biological Chemistry·Laura D HealyOwen J T McCarty
Jul 20, 2017·Proceedings of the National Academy of Sciences of the United States of America·Ravi Shankar KeshariFlorea Lupu
Oct 3, 2017·Frontiers in Immunology·Lysann BenderAndy T Long
Dec 20, 2017·Blood·Marcel Levi, Marie Scully
Apr 3, 2018·Haemophilia : the Official Journal of the World Federation of Hemophilia·O SalomonW Saliba
May 29, 2018·Haemophilia : the Official Journal of the World Federation of Hemophilia·D GailaniQ Cheng
Jul 15, 2018·Journal of Thrombosis and Haemostasis : JTH·B M MohammedD Gailani
Jul 22, 2018·Current Opinion in Hematology·Yi Wu
Aug 18, 2018·Cellular Signalling·Miroslava DidiasovaMalgorzata Wygrecka
Feb 1, 2019·Arteriosclerosis, Thrombosis, and Vascular Biology·Christina U LorentzErik I Tucker

❮ Previous
Next ❯

Citations

Sep 25, 2019·Journal of Thrombosis and Haemostasis : JTH·Ravi S KeshariFlorea Lupu
Dec 5, 2019·Blood·Ivan IvanovDavid Gailani
Apr 23, 2020·Arteriosclerosis, Thrombosis, and Vascular Biology·Xian LiJeremy P Wood
Jul 14, 2020·Arteriosclerosis, Thrombosis, and Vascular Biology·Nigel MackmanNigel S Key
Sep 21, 2020·Journal of Cellular and Molecular Medicine·Florea LupuKenneth Dormer
Sep 10, 2019·Journal of Cellular and Molecular Medicine·Mihnea P DragomirCatalin Vasilescu
Aug 3, 2020·Current Opinion in Hematology·Priyanka Srivastava, David Gailani
Jun 17, 2020·Research and Practice in Thrombosis and Haemostasis·Joseph J ShatzelAndras Gruber
Jul 12, 2019·Research and Practice in Thrombosis and Haemostasis·Vikram RaghunathanJoseph J Shatzel
Oct 28, 2020·Journal of Thrombosis and Haemostasis : JTH·Aleksandr ShamanaevDavid Gailani
Nov 19, 2020·ChemistryOpen·Srabani KarRami A Al-Horani
Sep 5, 2020·European Journal of Medicinal Chemistry·Clara DavoineLionel Pochet
Apr 4, 2021·The Journal of Immunology : Official Journal of the American Association of Immunologists·Cristina PuyOwen J T McCarty
Apr 20, 2021·Cellular and Molecular Bioengineering·T C L KohsM Wallisch
Jul 16, 2021·Blood·Helen Philippou
Sep 12, 2021·Proceedings of the National Academy of Sciences of the United States of America·Ravi Shankar KeshariFlorea Lupu

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.